2025 Strategic Plan
The ANA Board of Directors is looking forward to another great year in 2025. The infographic below highlights some goals set for 2025.
The ANA Board of Directors is looking forward to another great year in 2025. The infographic below highlights some goals set for 2025.
Thank you to all who supported and donated to ANA in 2024. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2025.
Here is a snapshot of the accomplishments from 2024 complete with links to information as appropriate.
ANA’s Board of Directors welcomes new member Michael Schain. Michael was born with sporadic aniridia and has a passion for improving outcomes for people with aniridia. For the past two years, he has served on the ANA Patient and Family Advisory Board. “We are so pleased to have Michael join our team,” said Peter Netland, ANA Board Chair. …
Guest: John Freeman, MD Dr. Freeman is Board Certified by the American Board of Ophthalmology and specializes in cataract surgery and corneal disease. Prior to receiving his medical degree, Dr. Freeman received his B.A. in English from Davidson College in North Carolina. Dr. Freeman earned his Medical Degree from the University of Tennessee College of …
ANA desires to increase collaboration internationally and serve as a collective voice of North American stakeholders to the international aniridia community. In pursuit of that vision, representatives from ANA were honored to be invited to and to participate in the 7th European Aniridia Conference, hosted by Aniridia Sweden, together with Linkoping University and Aniridia Europe. The …
On September 10th, 2024, the Second Congenital Aniridia and the WAGR Spectrum conference for Russian-speaking doctors and families with aniridia took place in Moscow, Russia. The conference was held at the “Crocus-Expo” International Exhibition Center as part of the International Optical Exhibition. 47 doctors and 97 patients and their family members from Russia and the …
Read how scientists are working to solve the aniridia puzzle. A patient-focused summary of presentations given at the 2023 ANA Symposium can be downloaded here.
Aniridia North America (ANA) is pleased to announce that our Board Chair, Dr. Peter Netland, is moving to Eastern Virginia Medical School (EVMS) in Norfolk, Virginia as Professor and Chair of the Department of Ophthalmology.
Thank you to all who supported and donated to ANA in 2023. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2024.
The infographics below provide a snapshot of the accomplishments in 2023 and highlight some goals set for 2024.
Thank you for your interest in furthering aniridia research by filling out the Aniridia and Neuropsychology survey. Below are the answers to Frequently Asked Questions about this survey. What is “Neuropsychology?” Neuropsychology is the study of the relationship between behavior, emotion, and the mind and their relationship to the central nervous system (the brain and spinal cord). …
Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525
Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.
EIN: 86-2917141